These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 5514986)

  • 1. Tumor-specific immunity induced by nontumorigenic 6C3HED ascites tissue culture cells.
    Eng CP; Kleine LP; Morgan JF
    J Natl Cancer Inst; 1970 Aug; 45(2):235-42. PubMed ID: 5514986
    [No Abstract]   [Full Text] [Related]  

  • 2. Further studies on tumor-specific immunity induced by nontumorigenic mouse ascites tissue-culture cells.
    Eng CP; Morgan JF
    Can J Microbiol; 1972 Jun; 18(6):775-81. PubMed ID: 4338315
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition and enhancement of the Landschütz ascites tumour with lymphoid cells.
    el-Hassan AM; Stuart AE
    J Pathol Bacteriol; 1966 Jan; 91(1):11-31. PubMed ID: 5941386
    [No Abstract]   [Full Text] [Related]  

  • 4. [The relationship between the level of mitotic activity of tumor cells and the periodic administration of anti-tumor sera].
    Sukhorukikh SV
    Biull Eksp Biol Med; 1967 Oct; 63(10):75-8. PubMed ID: 5622285
    [No Abstract]   [Full Text] [Related]  

  • 5. Native anti-tumor responses elicited by immunization with a low dose of unmodified live tumor cells.
    Wu S; Wang SQ; Zhang J; Tan XY; Liu JN
    Int J Oncol; 2006 Mar; 28(3):731-6. PubMed ID: 16465379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An attempt at in vitro sensitization of immunologically competent cells against tumour specific antigen.
    Koldovský P
    Folia Biol (Praha); 1966; 12(4):238-47. PubMed ID: 4287896
    [No Abstract]   [Full Text] [Related]  

  • 7. Mouse transplantable tumor induced by human spinal meningioma implant in mice inoculated with human thymus antiserum.
    Anigstein L; Anigstein DM; Unterharnscheidt FJ
    Tex Rep Biol Med; 1969; 27(2):341-66. PubMed ID: 4981726
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of fractionated histones on nucleic acid synthesis in 6C3HED mouse ascites tumor cells and in normal spleen cells.
    Levine AS; Nesbit ME; White JG; Yarbro JW
    Cancer Res; 1968 May; 28(5):831-44. PubMed ID: 5652298
    [No Abstract]   [Full Text] [Related]  

  • 9. Importance of cyclophosphamide-induced bystander effect on T cells for a successful tumor eradication in response to adoptive immunotherapy in mice.
    Proietti E; Greco G; Garrone B; Baccarini S; Mauri C; Venditti M; Carlei D; Belardelli F
    J Clin Invest; 1998 Jan; 101(2):429-41. PubMed ID: 9435316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
    Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP
    Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
    Wright SC; Bonavida B
    J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
    [No Abstract]   [Full Text] [Related]  

  • 12. An antigenic fraction of the lymphosarcoma 6C3HED of the C3H mouse.
    Paradise LJ; Nungester WJ
    Cancer Res; 1966 Jan; 26(1):110-5. PubMed ID: 5951787
    [No Abstract]   [Full Text] [Related]  

  • 13. Suppression of cell-mediated immunity through immune spleen cells against Ehrlich ascites tumor.
    Okubo S
    Nagoya J Med Sci; 1971 Mar; 33(4):329-40. PubMed ID: 5554418
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the murine plasma-cell neoplasm, X5563. II. Accelerated immunologic reactivity to transplanted tumor induced in C3H mice by transferred immune rabbit cells.
    Gordon BL II; Fong J
    Ann Allergy; 1967 Sep; 25(9):471-82. PubMed ID: 6053557
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of humoral immune responses and tumor immunity in mice immunized with recombinant SV40 large tumor antigen and a monoclonal anti-idiotype.
    Shearer MH; Bright RK; Kennedy RC
    Cancer Res; 1993 Dec; 53(23):5734-9. PubMed ID: 7694794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization by irradiated whole cells or cell extracts against an experimental bladder tumor.
    Morales A; Djeu J; Herberman RB
    Invest Urol; 1980 Jan; 17(4):310-3. PubMed ID: 7351363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of antitumor immunity of tumor-bearing mice with low-dose cyclophosphamide.
    Tzai TS; Lin JS; Chow NH
    J Surg Res; 1996 Oct; 65(2):139-44. PubMed ID: 8903460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hexokinase activity in tumorigenic and nontumorigenic cell cultures derived from mouse ascites tumor cells.
    Bhatnagar MK; Morgan JF
    J Natl Cancer Inst; 1971 Jul; 47(1):15-20 passim. PubMed ID: 5570115
    [No Abstract]   [Full Text] [Related]  

  • 19. Protective antitumor immunity induced by immunization with completely allogeneic tumor cells.
    Toes RE; Blom RJ; van der Voort E; Offringa R; Melief CJ; Kast WM
    Cancer Res; 1996 Aug; 56(16):3782-7. PubMed ID: 8706024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor regression in tumor-bearing mice by inoculations of immunogenic somatic hybrid cells in combination with cyclophosphamide.
    Tachibana T; Dei T
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):455-63. PubMed ID: 6681341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.